SCYNEXIS INC (NASDAQ:SCYX) has been identified by a specific screen that finds stocks fitting two different but connected investment methods: the technical rules of Mark Minervini's Trend Template and the strict fundamentals of high-growth momentum investing. This merged method aims to sort the market for businesses that are showing both solid, continued price movements and improving company fundamentals. The aim is to find stocks where notable technical momentum is confirmed by actual business progress, possibly presenting a good balance of risk and reward for investors aiming to benefit from new market leaders.
A Solid Technical Base: The Minervini Trend Template
The center of Mark Minervini's well-known method is his Trend Template, a precise group of technical rules made to confirm a stock is in a clear, strong uptrend before review. The template removes weak or consolidating stocks, concentrating only on those displaying definite institutional buying and strength. SCYX presently satisfies the important technical marks of this template, placing it in what Minervini calls a "Stage 2" upward move.
- Price Above Important Moving Averages: The stock's last price of $1.00 trades well above its rising 50-day ($0.83), 150-day ($0.77), and 200-day ($0.77) simple moving averages (SMAs). This order shows continued buying across short, medium, and long-term periods.
- Positive Moving Average Order: The 50-day SMA is above both the 150-day and 200-day SMAs, and the 150-day SMA is above the 200-day SMA. This bullish order, with shorter-term averages above longer-term ones, confirms a clear uptrend.
- Nearness to Highs: At $1.00, SCYX is trading within 25% of its 52-week high of $1.31 and is more than 30% above its 52-week low of $0.565. Minervini notes that real market leaders often trade close to their highs, not far below them.
- Better Relative Strength: With a ChartMill Relative Strength (CRS) score of 83.24, SCYX is doing better than more than 83% of the wider market. Strong relative strength is a key part of the method, finding stocks that are leading the market up instead of just following.
This technical view indicates SCYX has moved from a time of consolidation into a trending period, with supply being taken in and demand becoming dominant, a requirement for any stock in the Minervini method.
The Support for Momentum: High-Growth Fundamentals
While a strong chart is necessary, Minervini's SEPA (Specific Entry Point Analysis) method also requires solid and improving fundamentals. The "High Growth Momentum" part of the screening looks for businesses showing very fast growth in earnings and sales, which frequently acts as the driver for a continued price rise. SCYX shows several notable fundamental traits that fit this growth investor requirement.
The company's recent financial results display major improvement:
- Earnings Per Share (EPS) Growth: The EPS growth rate for the trailing twelve months (TTM) is about 59.6%, a notable year-over-year gain. More notably, the growth in the latest quarter compared to the same quarter last year increased by almost 369%.
- Revenue Speed Increase: Top-line growth is even more clear. Revenue over the TTM period has grown very fast, increasing by about 450%. The growth in the last quarter year-over-year was a remarkable 1,808%.
- Earnings Steadiness: The company has exceeded analyst EPS estimates in each of the past four quarters, with an average beat above 42%. It has also surpassed revenue estimates in all four quarters, with an average surprise above 259%. This steady outperformance can lead to positive analyst updates and more institutional attention.
- Profitability Change: Showing its commercial advance, the company reported a profit margin of 65.7% in its last quarter, a clear difference from the losses reported in earlier periods. This shift toward profitability is an important change for development-stage biotech companies.
These numbers show a business going through a fundamental change, probably driven by the commercial launch of its main antifungal drug, BREXAFEMME®. For a growth investor, this mix of fast sales increase, a move to profitability, and steady earnings surprises represents the kind of catalytic shift that can support a multi-quarter or multi-year uptrend.
Technical Condition and Setup Review
Beyond the exact Trend Template rules, a wider technical review of SCYX supports its strong position. According to ChartMill's own report, the stock receives a high Technical Rating of 9 out of 10, showing very good condition across several timeframes. Both the long-term and short-term trends are rated as positive. The report states that while the stock is trading in the higher part of its recent range, it has set clear support areas near the $0.82-$0.83 and $0.79 levels, giving possible zones for risk management.
The stock's Setup Rating is a moderate 5, indicating that after its recent strong move, it may be starting a phase of consolidation. For trend-following methods, such periods of pause after a rise can be normal, letting the stock gather strength for its next possible move higher. Investors would usually look for a new volatility contraction pattern (VCP) or an orderly decline to an important moving average as a possible lower-risk entry chance, following Minervini's focus on specific entry points.
You can review the full, detailed technical analysis for SCYX here: ChartMill Technical Report for SCYX.
Conclusion
SCYNEXIS INC presents a notable example of a stock that meets both technical and fundamental screens intended to find high-momentum growth. Its chart pattern satisfies the strict Minervini Trend Template, showing solid price trend condition and market-leading relative strength. At the same time, its core business is showing the kind of very fast revenue growth, moving profitability, and steady earnings beats that high-growth investors look for as a driver for continued performance.
It is important to note that such screens are beginning points for more study, not direct buy signals. The biotech sector has natural volatility and specific risks linked to clinical trials and commercial results. Any investment review must include a complete analysis of the company's pipeline, competitive environment, and financial health, along with careful risk management based on the technical pattern of the chart.
Interested in finding more stocks that fit this mix of solid trends and high growth? You can run the "High Growth Momentum + Trend Template" screen yourself to look at current market possibilities: Find More High Growth Trend Template Stocks.
Disclaimer: This article is for informational and educational purposes only. It is not intended as investment advice, nor does it constitute a recommendation to buy, sell, or hold any security. The analysis is based on data provided and screening methodologies described, which have inherent limitations. Investors should conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions. Past performance is not indicative of future results.